IL-1 Inhibitors: The Flare Treatment Held in Reserve

Most people managing gout will never be prescribed one of these, and that is exactly how it should be. IL-1 inhibitors are biologic medicines, and in gout they sit at the far end of the shelf, reached for only when the usual flare treatments are off the table.

Two come up in gout care: anakinra and canakinumab. You may see them under the brand names Kineret and Ilaris. Both are given by injection, both work on inflammation, and neither one lowers your uric acid. Hold on to that last point, because it changes what these drugs can and can't do for you.

A gout flare behaves a little like a fire alarm. Uric acid crystals settle in a joint, the body reads them as a threat, and an alarm goes off. The alarm here is a signaling protein called interleukin-1, usually shortened to IL-1. It is what summons the flood of heat, swelling, and pain you feel at three in the morning when the weight of a bedsheet on your toe is unbearable.

IL-1 inhibitors cut the wire to that particular alarm. Anakinra blocks the receptor that IL-1 uses to raise the signal; canakinumab targets the IL-1 protein itself. Either way, the alarm goes quiet and the flare settles. What they cannot do is clear the crystals or turn down the uric acid that formed them. They silence the alarm without touching what set it off.

Here is the rule of thumb behind the guidelines. For a gout flare, the first-line options are colchicine, an NSAID, or a course of steroids, and the American College of Rheumatology recommends all three strongly, with no single winner¹. IL-1 inhibitors are not on that list. They come into the picture only when those standard anti-inflammatories are poorly tolerated or genuinely can't be used, and even then the recommendation is a conditional one, not a strong one².

The evidence behind them is real, if narrow. A 2023 systematic review pulled together fourteen studies and more than four thousand people with gout, and concluded that IL-1 inhibitors may be a beneficial and mostly well tolerated option for flares when the usual treatments don't fit³. In a head-to-head trial, anakinra held its own against standard flare treatment, working about as well as colchicine, naproxen, or prednisone⁴.

So this is not an experimental drug or a shot in the dark. It is a well-studied option kept deliberately in reserve. If your doctor raises it, it usually means the safer, simpler, cheaper choices have already been ruled out for a good reason, often kidney disease, a bleeding risk, poorly controlled diabetes, or a heart problem that makes NSAIDs or steroids too risky to lean on.

This is specialist territory. IL-1 inhibitors are almost always started by a rheumatologist, not a GP, and getting hold of one is rarely quick. They are biologic drugs, which makes them far more expensive than a bottle of colchicine or a short steroid course, and insurers and health systems usually ask for proof that the cheaper options have already failed before they will cover them.

Because they work by dialing down part of your immune response, the main thing to watch for is infection. If you start one, your team will want to hear about any fever or sign of illness quickly, and they will usually check that you are not already fighting an infection before you begin. Soreness where the needle goes in is worth mentioning to them too, though across the studies done so far these drugs have been mostly well tolerated for gout flares³.

Come back to the point from earlier: IL-1 inhibitors do nothing to your uric acid. They can quiet a brutal flare when nothing else is safe to use, and that is genuinely valuable. But the crystals are still there the next morning, and the uric acid that keeps forming them is untouched.

The only way to end the cycle, rather than fight each flare as it arrives, is to lower the uric acid itself and keep it low. The ACR's position is to treat to a target, getting serum urate below 6 mg/dL and holding it there, so the crystals slowly dissolve and flares lose their fuel¹. That is a job for urate-lowering therapy like allopurinol, taken steadily over time, not for a flare drug reached for in a crisis. An IL-1 inhibitor is a fire blanket for a bad night. It was never meant to be the plan.